[Lead concentration in blood during treatment with coumarin derivatives].
D015110:4-Hydroxycoumarins / Q000627:therapeutic use*; D001491:Basophils; D001778:Blood Coagulation Disorders / Q000097:blood / Q000188:drug therapy; D006801:Humans; D007854:Lead / Q000097:blood*; D008134:Long-Term Care; D010644:Phenprocoumon / Q000009:adverse effects / Q000627:therapeutic use*; D012156:Reticulocytes
D015110:4-Hydroxycoumarins; D007854:Lead; D010644:Phenprocoumon
Bleikonzentration im Blut bei Behandlung mit Kumarinderivaten.